ストックスクリーナーアプリを入手
9.22
3.35%
-0.32
アフターアワーズ：
9.26
0.04
+0.43%
前日終値:
$9.54
開ける：
$9.4
24時間の取引高:
5.30M
Relative Volume:
0.96
時価総額：
$2.40B
収益：
$6.29B
当期純損益:
$750.00M
株価収益率:
3.2014
EPS:
2.88
ネットキャッシュフロー:
$586.00M
1週間 パフォーマンス:
+6.10%
1か月 パフォーマンス:
-29.94%
6か月 パフォーマンス:
-41.90%
1年 パフォーマンス:
-55.97%
1日の値動き範囲:
$9.17
$9.45
1週間の範囲:
$8.76
$9.615
52週間の値動き範囲:
$8.01
$23.10
Organon Co Stock (OGN) Company Profile
OGN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
OGN
Organon Co
|
9.22 | 2.26B | 6.29B | 750.00M | 586.00M | 2.88 |
|
LLY
Lilly Eli Co
|
737.67 | 640.72B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
155.21 | 367.98B | 89.33B | 21.81B | 18.57B | 8.99 |
|
ABBV
Abbvie Inc
|
186.11 | 323.71B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
115.76 | 222.69B | 53.22B | 12.86B | 14.85B | 6.39 |
|
NVO
Novo Nordisk Adr
|
71.50 | 299.26B | 43.59B | 15.04B | 10.74B | 3.3766 |
Organon Co Stock (OGN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2024-09-06 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2023-11-03 | ダウングレード | Goldman | Buy → Neutral |
| 2023-09-21 | 開始されました | Barclays | Overweight |
| 2023-03-16 | 開始されました | Raymond James | Outperform |
| 2022-10-14 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-09-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2022-08-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2022-04-27 | 開始されました | Goldman | Buy |
| 2022-04-06 | 再開されました | Morgan Stanley | Equal-Weight |
| 2021-10-07 | 開始されました | Piper Sandler | Neutral |
| 2021-09-01 | 開始されました | BofA Securities | Buy |
| 2021-07-22 | 開始されました | Citigroup | Buy |
| 2021-06-15 | 開始されました | JP Morgan | Neutral |
| 2021-06-11 | 開始されました | Morgan Stanley | Equal-Weight |
| 2021-06-10 | 開始されました | Evercore ISI | Outperform |
すべてを表示
Organon Co (OGN) 最新ニュース
OGN CLASS NOTICE: Organon & Co. Investors may have been - GlobeNewswire
OGN INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit - GlobeNewswire Inc.
Lost Money on Organon & Co. (OGN)? Urged to Join Class Action Before July 22, 2025Contact Levi & Korsinsky - ACCESS Newswire
ORGANON ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire
OGN Stockholders with Large Losses Should Contact Robbins LLP for Information About the Class Action Lawsuit Against Organon & Co. - PR Newswire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit - PR Newswire
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Levi & Korsinsky Urges Organon & Co. (OGN) Shareholders to Act Before Lead Plaintiff Deadline July 22, 2025 - ACCESS Newswire
Class Action Filed Against Organon & Co. (OGN)July 22, 2025 Deadline to Join – Contact Levi & Korsinsky - GlobeNewswire
Law Offices of Howard G. Smith Encourages Organon & Co. (OGN) Investors To Inquire About Securities Fraud Class Action - Business Wire
Did You Lose Money on Organon & Co. (OGN)? Levi & Korsinsky Urges Investors to Act Before July 22, 2025 - ACCESS Newswire
Shareholders who lost money on Organon & Co. (NYSE: OGN). Should Contact Wolf Haldenstein - GlobeNewswire
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - marketscreener.com
Shareholders that lost money on Organon & Co.(OGN) should contact Levi & Korsinsky about pending Class ActionOGN - PR Newswire
Why Organon & Co. (OGN) Surged On Thursday - Insider Monkey
Nuveen Asset Management LLC Reduces Stake in Organon & Co. (NYSE:OGN) - Defense World
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. - GlobeNewswire
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action – OGN - TradingView
Investors who lost money with shares of Organon & Co. (NYSE: OGN) - openPR.com
Levi & Korsinsky Notifies Organon & Co. (OGN) Shareholders of Class Action Lawsuit and July 22, 2025 Deadline - ACCESS Newswire
Shareholders of Organon & Co. Should Contact The Gross Law - GlobeNewswire
Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to ... - Bluefield Daily Telegraph
Shareholders of Organon & Co. Should Contact The Gross Law Firm Before July 22, 2025 to Discuss Your Rights – OGN - TradingView
Organon & Co. (OGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - Business Wire
Organon & Co (OGN) Stock Climbs Over 4%: A Value Signal with a Dividend Kicker? - Daily Chhattisgarh News
OGN INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
OGN REMINDER: Organon & Co. Investors with Losses are - GlobeNewswire
OGN REMINDER: Organon & Co. Investors with Losses are Notified of the Pending Securities Fraud Class Action – Contact BFA Law by July 22 Deadline (NYSE:OGN) - TradingView
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2025 in Organon LawsuitOGN - WV News
ORGANON BIOTHERAPEUTICS SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - GlobeNewswire
Investor Alert: Deadline Approaching to Join Organon & Co. (OGN) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Rosen Law Firm Urges Organon & Co. (NYSE: OGN) Stockholders With Large Losses to Contact the Firm for Information About Their Rights - Business Wire
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi ... - Bluefield Daily Telegraph
OGN BREAKING NEWS: Organon & Co. Stock Plummets 27% Triggering Shareholder Class Action – Contact BFA Law if You Lost Money (NYSE:OGN) - Business Wire
OGN Investors Have Opportunity to Lead Organon & Co. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC ... - Bluefield Daily Telegraph
ORGANON SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co. - GlobeNewswire Inc.
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Los - GuruFocus
Organon Receives FDA Interchangeability for HADLIMA - TipRanks
Drugmaker Organon Investor Sues After Quarterly Dividend Cut (1) - Bloomberg Law News
Sector Update: Health Care - marketscreener.com
Rosen Law Firm Encourages Organon & Co. Investors to Inquire About Securities Class Action Investigation – OGN - Business Wire
Bausch + Lomb, Organon, Globalstar, Telephone and Data Systems, and nLIGHT Shares Skyrocket, What You Need To Know - Yahoo
Organon, Samsung Bioepis Say FDA Grants Interchangeability Designation to Hadlima - marketscreener.com
US Food and Drug Administration (FDA) Grants Interchangeability Designation to Samsung Bioepis and Organon HADLIMA™ (adalimumab-bwwd) Injection - BioSpace
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
Organon’s SWOT analysis: healthcare firm’s stock shows growth potential - Investing.com Australia
ORGANON SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Organon & Co.OGN - Business Wire
Organon’s SWOT analysis: healthcare firm’s stock shows growth potential By Investing.com - Investing.com India
OGN INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire
Organon Co (OGN) 財務データ
収益
当期純利益
現金流量
EPS
0.17%
0.93%
大文字化:
|
ボリューム (24 時間):